Resilient Biotics
Company

Resilient Biotics

Biotechnology Research Durham, Nc, United States 11 employees
Employees
11
Contacts
3
Emails
3
Phones
2

Resilient Biotics Overview

Headquarters
Durham, Nc, United States
Industry
Biotechnology Research
Employees
11
Funding
7.2M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Resilient Biotics

Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. The company utilizes a proprietary discovery platform that incorporates high resolution genomic analyses, in-house machine learning algorithms, and targeted in vitro assays to identify naturally occurring microbiome-derived strains that have immune activation and pathogen inhibition properties in respiratory tissues. Resilient Biotics has a broad pipeline of actives addressing both viral and bacterial infectious diseases including positive in vivo efficacy data across multiple species.

Resilient Biotics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Resilient Biotics Org Chart

Sample employees and titles
Name Title Contact
Eric Easom CEO & Co-founder at An2 Therapeutics
Email Phone
Kinkead Reiling Founder and CEO @ Bonneville Labs - Biochemistry, Synthetic Biology
Email Phone
Todd Desantis V.p. - Founder - Builds Scalable Data Products for Life Sciences - Venturer, Predictive Index: 558-1701-597
View
Rachelle Galvin Passionate About Driving Ideas to Commercialization for Human and Animal Health. Experienced Drug Hunter and Scientific Leader.
Email

Employees by Management Level

Executive 3 profiles
Individual contributor 1 profile

Compare Similar Companies to Resilient Biotics